In neonates who are receiving either oral or IV DART (Dexamethasone) therapy for BPD, what is the physiologic reason as to why they have poor growth compared to those infants who are not on DART therapy?
This site uses cookies to help personalize content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies and terms of service.